1.
Terpos E, Gavriatopoulou M, Stathopoulos I, Malandrakis P, Kanellias N, Migkou M, Theodorakakou F, Solia E, Papaiakovou E, Kastritis E, Dimopoulos M. B06 | BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE/DEXAMETHASONE IN NEWLY DIAGNOSED INTERMEDIATE-FIT AND FRAIL MULTIPLE MYELOMA: LONG-TERM EFFICACY AND SAFETY FROM THE PHASE 1/2 BELARD CLINICAL TRIAL. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14094.